You are here

Syfovre

Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan

Tip Ranks

Tue, 11/19/24 - 11:13 am

geographic atrophy

Astellas doesn't see eye to eye with Europe on geographic atrophy drug Izervay

Fierce Pharma

Mon, 10/28/24 - 06:12 pm

geographic atrophy

Apellis cites current challenges with Syfovre launch but bright prospects in the long term

Fierce Pharma

Wed, 02/28/24 - 09:42 pm

Apellis Pharmaceuticals

geographic atrophy

Apellis Eye Injection Treatment Flagged for Safety Issues

BioSpace

Mon, 07/31/23 - 11:34 am

Apellis Pharmaceuticals

retinal vasculitis

Experts flag eye inflammation reports tied to Apellis' geographic atrophy med Syfovre

Fierce Pharma

Tue, 07/18/23 - 11:23 am

Apellis Pharmaceuticals

geographic atrophy

Apellis reports strong start for new vision loss drug

BioPharma Dive

Mon, 05/8/23 - 10:05 am

Apellis Pharmaceuticals

geographic atrophy

FDA Approves Apellis' Syfovre as First Treatment for Geographic Atrophy

BioSpace

Mon, 02/20/23 - 12:22 pm

Apellis Pharmaceuticals

geographic atrophy